1 domain / 1 area / 1 specialization
Perceptive Advisors
Also known as: Perceptive Advisors LLC
Data updated
Perceptive Advisors is a long-established life sciences investment manager based in New York. Its public materials describe a multi-strategy platform spanning life sciences, credit, capital solutions, and venture capital, with an emphasis on scientific diligence.
In psychedelic medicine, Perceptive's role is healthcare-adjacent rather than dedicated. The firm has a confirmed COMPASS Pathways financing record, which supports inclusion without implying that psychedelics are a central thematic focus for the platform.
Investor Context
Institutional InvestorsInvestment Context
This stakeholder is listed as an Institutional Investor within Institutional Investors. Its public geography context is global. Public stage signals include Multi-Stage and Public Markets. Public focus areas include Drug Development and Clinical Infrastructure.
Public Portfolio Examples
- COMPASS PathwaysSeries B - $80m - Apr 27, 2020
Perceptive Advisors is a specialist life-science investor with a confirmed COMPASS Pathways record. It is a useful example of institutional healthcare capital entering the sector through a specific financing rather than a public psychedelic-first strategy.
Investor Type
Institutional Investor
Geographic Scope
Global
Psychedelic Focus
Psychedelic-Adjacent Focus
Engagement
Active
Investment Stage Focus
Investment Focus Areas
Portfolio Stakeholders
Recorded Investments
Apr 27, 2020
Series B - $80m
Direct participation in a major psilocybin drug developer financing.
Mental health care company COMPASS Pathways concludes successful Series B investment roundQuick Facts
- Founded
- 1999
- HQ
- New York, United States
- Website
- Visit